|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
Dova Pharmaceuticals, Inc. (DOVA) |
|
|
$28.04 0.00 (0.00%) as of 4:30 Fri 2/14
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
25,652,000 |
| Market
Cap: |
719.28(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$28.04 - $28.04 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-08 |
2023-11-07 |
2023-05-09 |
2022-05-09 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Edelman Joseph |
10% Owner |
– – • |
2019-07-09 |
4 |
B |
$16.61 |
$495,543 |
I/I |
29,834 |
3,653,435 |
1.5 |
- |
|
| Edelman Joseph |
10% Owner |
– – • |
2019-07-05 |
4 |
B |
$16.46 |
$823,000 |
I/I |
50,000 |
3,632,601 |
1.5 |
- |
|
| Edelman Joseph |
10% Owner |
– – • |
2019-07-03 |
4 |
B |
$16.67 |
$28,422 |
I/I |
1,705 |
3,573,601 |
1.5 |
- |
|
| Zaccardelli David |
President & CEO |
• • – |
2019-07-02 |
4 |
AS |
$15.73 |
$166,608 |
D/D |
(10,450) |
81,922 |
|
- |
|
| Edelman Joseph |
10% Owner |
– – • |
2019-07-02 |
4 |
B |
$16.14 |
$11,540 |
I/I |
715 |
3,571,896 |
1.5 |
- |
|
| Edelman Joseph |
10% Owner |
– – • |
2019-07-01 |
4 |
B |
$14.24 |
$258,043 |
I/I |
18,121 |
3,571,181 |
1.5 |
- |
|
| Jeffs Roger |
Director |
– • – |
2019-07-01 |
4 |
AS |
$14.17 |
$18,534 |
D/D |
(1,308) |
66,993 |
|
- |
|
| Hahn Mark W |
Chief Financial Officer |
• – – |
2019-07-01 |
4 |
AS |
$14.17 |
$21,893 |
D/D |
(1,545) |
9,799 |
|
- |
|
| Allen Lee F Md Phd |
Chief Medical Officer |
• – – |
2019-07-01 |
4 |
AS |
$14.19 |
$27,770 |
D/D |
(1,957) |
10,613 |
|
- |
|
| Laliberte Kevin |
Sr. VP, Product Development |
• – – |
2019-07-01 |
4 |
AS |
$14.17 |
$16,876 |
D/D |
(1,191) |
12,946 |
|
- |
|
| Hoitt Jason |
Chief Commercial Officer |
• – – |
2019-06-28 |
4 |
AS |
$13.77 |
$32,963 |
D/D |
(2,387) |
19,937 |
|
- |
|
| Edelman Joseph |
10% Owner |
– – • |
2019-06-28 |
4 |
B |
$13.97 |
$1,417,085 |
I/I |
100,000 |
3,553,060 |
1.5 |
- |
|
| Edelman Joseph |
10% Owner |
– – • |
2019-06-27 |
4 |
B |
$12.46 |
$4,286,124 |
I/I |
327,209 |
3,453,060 |
1.5 |
- |
|
| Goldman Steven M. |
Director |
– • – |
2019-06-26 |
4 |
OE |
$7.32 |
$14,511 |
D/D |
1,750 |
144,280 |
|
- |
|
| Goldman Steven M. |
Director |
– • – |
2019-06-20 |
4 |
OE |
$7.32 |
$14,509 |
D/D |
1,750 |
142,530 |
|
- |
|
| Goldman Steven M. |
Director |
– • – |
2019-05-13 |
4 |
OE |
$7.32 |
$26,850 |
D/D |
3,668 |
140,780 |
|
- |
|
| Hoitt Jason |
Chief Commercial Officer |
• – – |
2019-04-08 |
4 |
AS |
$8.77 |
$20,934 |
D/D |
(2,387) |
22,324 |
|
- |
|
| Manning Paul B |
Director |
– • • |
2019-03-07 |
4 |
B |
$7.48 |
$508,640 |
D/D |
68,000 |
12,950,954 |
3.92 |
- |
|
| Jeffs Roger |
Director |
– • – |
2019-02-05 |
4 |
A |
$0.00 |
$0 |
D/D |
6,901 |
68,301 |
|
- |
|
| Novak Alfred J |
Director |
– • – |
2019-02-05 |
4 |
A |
$0.00 |
$0 |
D/D |
6,901 |
6,901 |
|
- |
|
| Wysenski Nancy |
Director |
– • – |
2019-02-05 |
4 |
A |
$0.00 |
$0 |
D/D |
6,274 |
6,274 |
|
- |
|
| Goldman Steven M. |
Director |
– • – |
2019-02-05 |
4 |
A |
$0.00 |
$0 |
D/D |
7,528 |
132,529 |
|
- |
|
| Hahn Mark W |
Chief Financial Officer |
• – – |
2019-01-04 |
4 |
A |
$0.00 |
$0 |
D/D |
8,844 |
11,344 |
|
- |
|
| Laliberte Kevin |
Sr. VP, Product Development |
• – – |
2019-01-04 |
4 |
A |
$0.00 |
$0 |
D/D |
7,937 |
14,137 |
|
- |
|
| Allen Lee F Md Phd |
Chief Medical Officer |
• – – |
2019-01-04 |
4 |
A |
$0.00 |
$0 |
D/D |
9,070 |
12,570 |
|
- |
|
91 Records found
|
|
Page 2 of 4 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
